These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 801077)

  • 21. Effect of anti-HLA antibodies on the long-term survival of heart and kidney allografts.
    Barr ML; Cohen DJ; Benvenisty AI; Hardy M; Reemtsma K; Rose EA; Marboe CC; D'Agati V; Suciu-Foca N; Reed E
    Transplant Proc; 1993 Feb; 25(1 Pt 1):262-4. PubMed ID: 8438294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The improving prognosis after kidney transplantation. New strategies to overcome immunologic rejection.
    Levey AS
    Arch Intern Med; 1984 Dec; 144(12):2382-7. PubMed ID: 6391406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific HLA antibody production following renal transplantation.
    Martin S; Dyer PA; Gokal R; Mallick NP; Johnson RW
    Transplant Proc; 1987 Feb; 19(1 Pt 1):898. PubMed ID: 3274885
    [No Abstract]   [Full Text] [Related]  

  • 24. Recombinant human erythropoietin decreases anti-HLA sensitization and may improve renal allograft outcome: involvement of anti-idiotypic antibody.
    Grimm PC; Sekiya NM; Robertson LS; Robinson BJ; Ettenger RB
    Transplant Proc; 1991 Feb; 23(1 Pt 1):407-8. PubMed ID: 1990568
    [No Abstract]   [Full Text] [Related]  

  • 25. Detection of anti-idiotypic antibodies to HLA (anti-anti-HLA antibodies) by use of human monoclonal antibodies.
    Pistillo MP; Ferrara GB; Reed E; Brensilver J; McCabe R; Benvensity A; Hardy M; King DW; Suciu-Foca N
    Transplant Proc; 1989 Feb; 21(1 Pt 1):760-1. PubMed ID: 2650260
    [No Abstract]   [Full Text] [Related]  

  • 26. Disappearance of anti-HLA antibodies in highly sensitized patients treated with erythropoietin.
    Mourad G; Cristol JP; Chong G; Lorho R; Argiles A; Seignalet J; Mion C
    Transplant Proc; 1992 Dec; 24(6):2512-3. PubMed ID: 1465849
    [No Abstract]   [Full Text] [Related]  

  • 27. Is HL-A typing of clinical significance in cadaver renal transplantation?
    Belzer FO; Perkins HA; Fortmann JL; Kountz SL; Salvatierra O; Cochrum KC; Payne R
    Lancet; 1974 Apr; 1(7861):774-7. PubMed ID: 4132709
    [No Abstract]   [Full Text] [Related]  

  • 28. Statistical report of the European Dialysis and Transplant Association.
    Proc Eur Dial Transplant Assoc; 1975; 11():3-67. PubMed ID: 1105551
    [No Abstract]   [Full Text] [Related]  

  • 29. Histocompatibility testing in clinical renal transplantation.
    Braun WE
    Urol Clin North Am; 1983 May; 10(2):231-42. PubMed ID: 6222529
    [No Abstract]   [Full Text] [Related]  

  • 30. Renal function, recovery and rehabilitation after kidney transplantation: an analysis of 30 consecutive patients.
    Diethelm AG; Cobbs CG; Hartley M; Shaw JF; Morgan JM
    Am Surg; 1971 Oct; 37(10):622-36. PubMed ID: 4939717
    [No Abstract]   [Full Text] [Related]  

  • 31. Transplant-induced donor-specific antibodies and graft outcome.
    Martin S; Dyer PA; Mallick NP; Gokal R; Johnson RW
    Transplant Proc; 1987 Feb; 19(1 Pt 1):899-90. PubMed ID: 3274886
    [No Abstract]   [Full Text] [Related]  

  • 32. Kidney transplantation.
    Ellis F
    Trans Med Soc Lond; 1975; 91():38-54. PubMed ID: 800696
    [No Abstract]   [Full Text] [Related]  

  • 33. Studies of the antibodies against HLA, Ia-like, Fc, and/or C3 receptors present in pretransplant sera: anti-B-cell antibodies not associated with accelerated graft loss.
    Soulillou JP; Peyrat MA; Guenel J
    Transplant Proc; 1978 Jun; 10(2):475-7. PubMed ID: 354139
    [No Abstract]   [Full Text] [Related]  

  • 34. Possible rejection of an HL-A identical sibling renal allograft.
    d'Apice JF; Morris PJ; Kincaid-Smith P; Mathew TH; Marshall VC
    Med J Aust; 1976 Feb; 1(7):195-7. PubMed ID: 131902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunologic and transplantation biology studies in patients with terminal renal failure].
    Lanzer G
    Wien Med Wochenschr Suppl; 1985; 89():1-48. PubMed ID: 3892933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histocompatibility typing and corneal transplantation.
    Allansmith MR; Fine M; Payne R
    Trans Am Acad Ophthalmol Otolaryngol; 1974; 78(3):OP445-60. PubMed ID: 4601136
    [No Abstract]   [Full Text] [Related]  

  • 37. Antigens of mammalian cell surface and their corresponding antibodies.
    Milgrom F
    Transplant Proc; 1979 Mar; 11(1):816-21. PubMed ID: 377715
    [No Abstract]   [Full Text] [Related]  

  • 38. Value of donor-specific antibody detection in first-graft renal transplant recipients with a negative complement-dependent cytotoxic crossmatch.
    Mahmoud KM; Ismail AM; Sheashaa HA; Gheith OA; Kamal MM; Ghoneim MA
    Exp Clin Transplant; 2009 Jun; 7(2):124-8. PubMed ID: 19715518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absence of irreversible rejection in the presence of warm anti-donor-HLA class I cytotoxic IgG antibody.
    Shoker A; Klassen J; Herbut B
    Clin Nephrol; 1997 Feb; 47(2):87-91. PubMed ID: 9049455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between the presence of anti-HLA antibodies with acute rejection and chronic allograft nephropathy in the first year after kidney transplantation.
    Toresan R; Manfro RC; Proença MC; Veronese FJ; Salim PH; da Silva DM; Ribeiro AR; Edelweiss MI; Pegas KL; Jobim LF
    Transplant Proc; 2008 Apr; 40(3):718-9. PubMed ID: 18454996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.